Bioimmunate Technologies Overview
Bioimmunate is a medical device company that offers a precision blood filtering medical technology for select autoimmune diseases. The companys platform technology is initially focused on the treatment of patients with multiple sclerosis (MS). Brain damage from MS is caused by specific MS-related cells that migrate from the blood to the brain. Bioimmunate has developed unique biological filters anchored inside special particles that are able to recognize, capture, and remove these harmful cells from the patients blood before they reach the central nervous system. Bioimmunate is dedicated to improving the quality of life of patients with autoimmune diseases, seeking to provide safer, more cost-effective therapies without side effects. The companys main R&D lab is located at the BioGiv Center at the Hebrew University in Jerusalem.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1.95M |
| Last funding | $1M |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.bioimmunate.com/ |
Locations
Professor Racah St 3, Jerusalem, Israel
Photos & Videos
1 item(s)
Bioimmunate Technologies Business
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
BiologicalsCellsTags (7)
multiple-sclerosismedical-technologiesmedical-deviceshospitalspatientsautoimmune-diseasesbioconvergenceBioimmunate Technologies Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Bioimmunate Technologies Lifecycle
Cumulative Funding Raised Over Time
All Events
Bioimmunate Technologies News
0 articlesNo news articles.
Bioimmunate Technologies Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 7 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Bioimmunate Technologies Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 97/100 |
| Missing | news, external profiles |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515101384 |
| Crunchbase | bioimmunate-technologies |
| Phone | +97225649302 |
| Last updater | Natasha Voloshin |
| Updater email | natashavolo@gmail.com |
| Last update | 2020-11-04T00:00:00.000Z |
| Created | 2017-11-22T00:00:00.000Z |
| Claimed | Yes |